Approvals/TGA/DUAVIVE 0.45/20 conjugated estrogens/bazedoxifene (as acetate) 0.45 mg/20 mg modified release tablet blister pack

Approved

STANDARD

DUAVIVE 0.45/20 conjugated estrogens/bazedoxifene (as acetate) 0.45 mg/20 mg modified release tablet blister pack

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2a66ffdc1694736c
Product Name: DUAVIVE 0.45/20 conjugated estrogens/bazedoxifene (as acetate) 0.45 mg/20 mg modified release tablet blister pack
Artg Id: 262525
Artg Name: DUAVIVE 0.45/20 conjugated estrogens/bazedoxifene (as acetate) 0.45 mg/20 mg modified release tablet blister pack
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2016-12-15
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

2a66ffdc1694736c

Type

Standard